Cleared Traditional

K971763 - BLOOD COLLECTION TUBE HOLDER VANISHPOINT TUBE HOLDER/SMALL TUBE ADAPTER

K971763 is an FDA 510(k) clearance for BLOOD COLLECTION TUBE HOLDER VANISHPOIN..., manufactured by Retractable Technologies, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K971763 · Retractable Technologies, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
105d
Days
Class 2
Risk

K971763 is an FDA 510(k) clearance for the BLOOD COLLECTION TUBE HOLDER VANISHPOINT TUBE HOLDER/SMALL TUBE ADAPTER. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Retractable Technologies, Inc. (Little Elm, US). The FDA issued a Cleared decision on August 26, 1997 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Retractable Technologies, Inc. devices

FDA 510(k) Submission Details - K971763

510(k) Number K971763 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 13, 1997
Decision Date August 26, 1997
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 537
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K971763.
BKMI DISPOSABLE SYRINGE
K971487 · Sumi Salud C.A. · Sep 1997
SHARPS SHUTTLE
K972279 · Sage Products, Inc. · Aug 1997
SELFSHIELD HN SELF SHEATHING HYPODERMIC NEEDLE
K972469 · Beech Medical Products, Inc. · Aug 1997
SYRINGE NEEDLE REMOVER (S.N.R.)
K972536 · Post Medical, Inc. · Aug 1997
ISOLYSER SDS SHARPS CONTAINER
K970547 · Thantex Specialties, Inc. · Jul 1997
SHARPS CONTAINER
K970383 · Custom Medical Plastics, Inc. · Jul 1997